Global Population Genomics Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Population Genomics Market Expected To Become By 2029 Compared With Its 2025 Level?

The population genomics market has seen rapid expansion in recent years. It is anticipated to grow from $7.22 billion in 2024 to $8.25 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.2%. The historical increase can be ascribed to several factors, including augmented investment in genomic research, the proliferation of genomic service providers, the rise of direct-to-consumer genomics services, an uptick in government funding for genomics initiatives, and the expansion of genomic research infrastructure.

The population genomics market size is anticipated to experience substantial expansion in the forthcoming years. It is predicted to reach $13.84 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.8%. This growth over the forecast period stems from factors such as the increasing prevalence of genetic disorders, a rise in cancer incidence, the escalating burden of rare diseases, the growing requirement for personalized medicine, and the enhanced integration of genomics into clinical diagnostics. Significant trends anticipated during this period involve advancements in next-generation sequencing, the progression of single-cell genomics, the incorporation of artificial intelligence in genomic analysis, the miniaturization of sequencing platforms, and improvements in bioinformatics tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28305&type=smp

Which Drivers Are Supporting Growth Of The Population Genomics Market?

The increasing need for personalized medicine is anticipated to fuel the expansion of the population genomics market in the future. Personalized medicine involves customizing medical treatments to an individual’s unique genetic makeup. This growing need is attributed to the falling costs of genomic technologies, which are making targeted therapies more widely accessible. Population genomics aids personalized medicine by uncovering genetic differences prevalent within particular groups, allowing healthcare professionals to tailor therapies and medications for enhanced efficacy and safety, considering an individual’s genetic profile. For example, in February 2024, data from the US-based non-profit organization, the Personalized Medicine Coalition, indicated that the FDA approved 16 novel personalized treatments for patients with rare diseases in 2023, a significant increase from the six approvals recorded in 2022. Consequently, the heightened demand for personalized medicine is propelling the development of the population genomics market.

What Are The Segment Types Shaping The Population Genomics Market?

The population genomics market covered in this report is segmented as

1) By Product Service: Consumables, Instruments, Services, Software

2) By Sample Type: Human, Animal, Plant, Microbial

3) By Application: Pharmacogenomics, Disease Research, Ancestry And Evolution, Personalized Medicine, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Probes And Assay Panels, Enzymes, Buffers And Media, Sample Collection And Storage Materials

2) By Instruments: Sequencers, PCR And qPCR Instruments, Microarray Platforms, Sample Preparation And Extraction Instruments, Imaging Systems, Automation And Robotics Systems

3) By Services: Sequencing Services, Genotyping Services, Bioinformatics And Data Analysis Services, Sample Preparation Services, Custom Assay Development

4) By Software: Data Analysis Software, Genome Assembly Software, Variant Calling And Annotation Software, Cloud-Based Genomics Platforms, Laboratory Information Management Systems (LIMS)

What Trends Are Expected To Drive The Population Genomics Market?

Major companies engaged in the population genomics market are prioritizing the development of advanced solutions, including ultra-high throughput library preparation kits, to maintain exceptional consistency and accuracy across numerous samples. Ultra-high throughput library preparation kits are tools engineered to rapidly and efficiently prepare hundreds or thousands of DNA or RNA samples for sequencing within a unified workflow. For example, in October 2024, Twist Bioscience Corporation, a US-based biotechnology company, introduced FlexPrep, an ultra-high throughput library preparation kit specifically for population genomics. This product incorporates a unique Normalization by Ligation (NBL) technology that improves upon conventional enzymatic fragmentation methods. This technology obviates the need for laborious upfront sample quantification and permits early pooling and multiplexing of samples. Its integrated normalization and multiplexing features simplify the handling of varying sample quantities, thereby enhancing workflow efficiency and cutting per-sample costs for large-scale NGS projects. Furthermore, the kit includes a proprietary enzyme developed by Twist, supporting high-throughput processing at lower costs and encouraging the broader adoption of NGS in population genomics.

Which Leading Players Are Enhancing Their Population Genomics Market Presence Worldwide?

Major companies operating in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/population-genomics-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Population Genomics Market?

North America was the largest region in the population genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in population genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Population Genomics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28305&type=smp

Browse Through More Reports Similar to the Global Population Genomics Market 2025, By The Business Research Company

Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Ai In Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795